|
Biotechnology
Biotechnology holds vast promise for meeting some of the world’s most pressing needs. At the same time, important questions are being asked about this family of technologies as part of a broad public dialogue that includes individuals, organizations, companies, academia, and governments.
We understand that these questions and concerns need to be addressed both in the context of science and in light of biotechnology’s unique philosophical and ethical implications. To this end, Dow is engaged in dialogue with external stakeholders. We value these relationships for the perspective they contribute, the guidance they offer, and the opportunity they present for understanding societal concerns. In consultation with external stakeholder groups, we developed and implemented The Dow Chemical Company Guiding Principles for Biotechnology to further direct our approach and actions.
At the same time, we are committed and prepared to develop biotechnology-based capabilities and biotechnology-enabled businesses in a scientifically sound and responsible manner. We align our activities with Responsible Care® as well as Dow’s Values, Code of Business Conduct, and Sustainable Development Principles. We are hopeful that by considering biotechnology in an open, informed, and transparent process, and combined with scientific understanding, stakeholders can approach common ground, and this new set of technological tools can deliver on its promise.
Responsible Care® is a registered service mark of the American Chemistry Council.
|
